-Merck's Phase Ii/Iii Clinical Trial of Staphylococcus Aureus Vaccine V710 Suspends Enrolment
M2 EquityBites › April 11, 2011
Linked as:
M2 EquityBites › April 11, 2011
Linked as:Summary
M2 EQUITYBITES-April 11, 2011-Merck's Phase II/III clinical trial of Staphylococcus aureus Vaccine V710 suspends enrolment
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
-Merck's Phase Ii/Iii Clinical Trial of Staphylococcus Aureus Vaccine V710 Suspends Enrolment
Healthcare company Merck (NYSE:MRK) (MSD ou...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Future Para Dressage Stars Spotted ; Two Disabled Riders From the South West Have Been Honoured at the 2009 Para Equestrian Dressa... | Win Double Keeps Darlo Hopes Alive Darlington 2 Rotherham United 0 | help needed with darch family tree | Approval Despite Flooding Fears | Correcting the Record | vornado loses bidding war | Collared at the Lounge | a new-found exuberance